Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Monopar Therapeutics (MNPR) News Today

→ Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad)
Free MNPR Stock Alerts
$0.61
-0.01 (-1.21%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
May 13, 2024 | americanbankingnews.com
Monopar Therapeutics (NASDAQ:MNPR) Earns "Buy" Rating from HC Wainwright
May 11, 2024 | americanbankingnews.com
Monopar Therapeutics Inc. (NASDAQ:MNPR) Sees Significant Drop in Short Interest
May 10, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Monopar Therapeutics on Strategic Shift and Pipeline Potential
May 9, 2024 | investorplace.com
MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024
May 9, 2024 | finanznachrichten.de
Monopar Therapeutics Inc.: Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 9, 2024 | markets.businessinsider.com
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 9, 2024 | globenewswire.com
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 1, 2024 | investing.com
Monopar Therapeutics Inc (MNPR)
April 18, 2024 | globenewswire.com
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
April 16, 2024 | msn.com
Monopar files patent protecting its MNPR-101 radiopharma optimization findings
April 16, 2024 | finance.yahoo.com
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 11, 2024 | markets.businessinsider.com
Buy Rating on Monopar Therapeutics: Promising Trials and Financial Stability Highlight Growth Potential
April 10, 2024 | globenewswire.com
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
March 28, 2024 | finance.yahoo.com
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
March 28, 2024 | globenewswire.com
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
March 6, 2024 | marketwatch.com
Monpar Therapeutics Shares Rise 12% After Positive Preclinical Data for MNPR-101
March 5, 2024 | markets.businessinsider.com
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
March 5, 2024 | globenewswire.com
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
February 27, 2024 | globenewswire.com
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
February 24, 2024 | cnn.com
Monopar Therapeutics Inc
February 23, 2024 | markets.businessinsider.com
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
February 22, 2024 | msn.com
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
February 22, 2024 | msn.com
Monopar stock jumps 60% amid preclinical data for MNPR-101
February 22, 2024 | finance.yahoo.com
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
February 20, 2024 | benzinga.com
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
February 20, 2024 | marketwatch.com
Monopar Therapeutics Shares Surge on Australia Antibody-Trial Clearance
February 20, 2024 | msn.com
Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday?
February 20, 2024 | marketbeat.com
Trading was temporarily halted for "MNPR" at 10:02 AM with a stated reason of "LULD pause."
February 20, 2024 | marketbeat.com
Trading was temporarily halted for "MNPR" at 10:02 AM with a stated reason of "LULD pause." Trading set to resume at 10:02 AM.
February 20, 2024 | finance.yahoo.com
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
February 20, 2024 | marketbeat.com
Trading was temporarily halted for "MNPR" at 09:02 AM with a stated reason of "LULD pause."
February 20, 2024 | marketbeat.com
Trading was temporarily halted for "MNPR" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM.
February 20, 2024 | marketbeat.com
Trading was temporarily halted for "MNPR" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM.
February 20, 2024 | globenewswire.com
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
February 10, 2024 | reuters.com
Kyverna Therapeutics Inc
January 7, 2024 | finance.yahoo.com
Monopar Therapeutics Inc. (MNPR)
November 9, 2023 | finance.yahoo.com
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 9, 2023 | finance.yahoo.com
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 9, 2023 | finance.yahoo.com
Monopar Therapeutics Inc Reports Q3 2023 Financial Results and Progress in Clinical Programs
November 3, 2023 | markets.businessinsider.com
Promising Early Efficacy Results and Diverse Drug Development Portfolio Drive ‘Buy’ Rating for Monopar Therapeutics Inc
November 1, 2023 | finance.yahoo.com
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
October 10, 2023 | finance.yahoo.com
Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference
September 5, 2023 | finance.yahoo.com
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 5, 2023 | finance.yahoo.com
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
August 10, 2023 | finance.yahoo.com
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments
August 8, 2023 | finance.yahoo.com
Monopar Provides Encouraging Camsirubicin Clinical Data Update
August 8, 2023 | finance.yahoo.com
Monopar Provides Encouraging Camsirubicin Clinical Data Update
July 11, 2023 | finance.yahoo.com
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
July 11, 2023 | finance.yahoo.com
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
June 21, 2023 | finance.yahoo.com
Monopar to Participate in the Radiopharma Forum by the Lake 2023
Get Monopar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNPR and its competitors with MarketBeat's FREE daily newsletter.

Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

MNPR Media Mentions By Week

MNPR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MNPR
News Sentiment
▼
-0.50

0.42
▲
Average
Medical
News Sentiment

MNPR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MNPR Articles
This Week
▼
1

1
▲
MNPR Articles
Average Week

Get Monopar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNPR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:MNPR) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace
Most important medical advance in 100 years
The Oxford Club